Englander Institute for Precision Medicine

Characterization of Bulk Phosphatidylcholine Compositions in Human Plasma Using Side-Chain Resolving Lipidomics.

TitleCharacterization of Bulk Phosphatidylcholine Compositions in Human Plasma Using Side-Chain Resolving Lipidomics.
Publication TypeJournal Article
Year of Publication2019
AuthorsQuell JD, Römisch-Margl W, Haid M, Krumsiek J, Skurk T, Halama A, Stephan N, Adamski J, Hauner H, Mook-Kanamori D, Mohney RP, Daniel H, Suhre K, Kastenmüller G
JournalMetabolites
Volume9
Issue6
Date Published2019 Jun 08
ISSN2218-1989
Abstract

Kit-based assays, such as Absolute p150, are widely used in large cohort studies and provide a standardized method to quantify blood concentrations of phosphatidylcholines (PCs). Many disease-relevant associations of PCs were reported using this method. However, their interpretation is hampered by lack of functionally-relevant information on the detailed fatty acid side-chain compositions as only the total number of carbon atoms and double bonds is identified by the kit. To enable more substantiated interpretations, we characterized these PC sums using the side-chain resolving Lipidyzer platform, analyzing 223 samples in parallel to the Absolute. Combining these datasets, we estimated the quantitative composition of PC sums and subsequently tested their replication in an independent cohort. We identified major constituents of 28 PC sums, revealing also various unexpected compositions. As an example, PC 16:0_22:5 accounted for more than 50% of the PC sum with in total 38 carbon atoms and 5 double bonds (PC aa 38:5). For 13 PC sums, we found relatively high abundances of odd-chain fatty acids. In conclusion, our study provides insights in PC compositions in human plasma, facilitating interpretation of existing epidemiological data sets and potentially enabling imputation of PC compositions for future meta-analyses of lipidomics data.

DOI10.3390/metabo9060109
Alternate JournalMetabolites
PubMed ID31181753
PubMed Central IDPMC6631474
Grant ListRF1 AG058942-01 / / National Institute on Aging /
R01-AG057452-01 / / National Institute on Aging /
R01-AG059093-01 / / National Institute on Aging /
U01-AG061359-01 / / National Institute on Aging /
NPRP8-061-3-011 / / Qatar National Research Fund /

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021